Serum levels of CK-18-M30, FGF-21, IL-1Ra and PEDF increased, while OPG decreased in a stepwise fashion in controls, non-NASH NAFLD patients and NASH patients (P < 0.01). This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatohepatitis.